抗焦虑药减轻良性阵发性位置性眩晕在管石复位成功后的残余头晕感

HAHN JIN JUNG, JA-WON KOO, CHONG SUN KIM, 等. 抗焦虑药减轻良性阵发性位置性眩晕在管石复位成功后的残余头晕感[J]. 临床耳鼻咽喉头颈外科杂志, 2013, 27(5): 259-263. doi: 10.13201/j.issn.1001-1781.2013.05.014
引用本文: HAHN JIN JUNG, JA-WON KOO, CHONG SUN KIM, 等. 抗焦虑药减轻良性阵发性位置性眩晕在管石复位成功后的残余头晕感[J]. 临床耳鼻咽喉头颈外科杂志, 2013, 27(5): 259-263. doi: 10.13201/j.issn.1001-1781.2013.05.014
HAHN JIN JUNG, JA-WON KOO, CHONG SUN KIM, et al. Anxiolytics reduce residual dizziness after successful canalith repositioning maneuvers in benign paroxysmal positional vertigo[J]. J Clin Otorhinolaryngol Head Neck Surg, 2013, 27(5): 259-263. doi: 10.13201/j.issn.1001-1781.2013.05.014
Citation: HAHN JIN JUNG, JA-WON KOO, CHONG SUN KIM, et al. Anxiolytics reduce residual dizziness after successful canalith repositioning maneuvers in benign paroxysmal positional vertigo[J]. J Clin Otorhinolaryngol Head Neck Surg, 2013, 27(5): 259-263. doi: 10.13201/j.issn.1001-1781.2013.05.014

抗焦虑药减轻良性阵发性位置性眩晕在管石复位成功后的残余头晕感

详细信息
  • 中图分类号: R764.3

Anxiolytics reduce residual dizziness after successful canalith repositioning maneuvers in benign paroxysmal positional vertigo

  • 目的: 管石复位治疗(CRP)能有效治疗良性阵发性位置性眩晕(BPPV),但许多患者在CRP治疗成功后仍有持续的头晕感。本研究的目的在于评价抗焦虑药物辅助治疗对CRP治疗成功后残余头晕感的疗效。方法: 2011-01-2011-03期间73例BPPV患者接受CRP治疗成功,并随机分为药物组和对照组。药物组患者服用低剂量的依替唑仑2周,对照组患者不用药。所有患者在进行主观垂直视觉检查后2周复诊,采用头晕残障量表(DHI)和特定活动平衡信心量表(ABC)评价CRP治疗前后的主观症状变化。结果: 2组患者的DHI得分均显著升高,但药物组患者在DHI功能和情绪的分量表分数以及总分上的下降更加显著。结论: 本研究表明,抗焦虑药物可能对接受了CRP的BPPV的患者有效。
  • 加载中
  • [1]

    DIX M R,HALLPIKE C S.The pathology,symptomatol-ogy and diagnosis of certain common disorders of the ves-tibular system[J].Ann Otol Rhinol Laryngol,1952,61:987-1016.

    [2]

    FIFE T D,IVERSON D J,LEMPERT T,et al. Practice parameter:therapies for benign paroxysmal positional vertigo(an evidence-based review):report of the Quality Standards Subcommittee of the American Academy of Neurology[J]. Neurology,2008,70:2067-2074.

    [3]

    LOPEZ-ESCAMEZ J,GONZALEZ-SANCHEZ M,SALIN-ERO J.Meta-analysis of the treatment of benign paroxys-mal positional vertigo by Epley and Semont maneuvers[J].Acta Otorrinolaringol Esp,1999,50:366-370.

    [4]

    WOODWORTH B A,GILLESPIE M B,LAMBERT P R.The canalith repositioning procedure for benign positional vertigo:a meta-analysis[J]. Laryngoscope,2004,114:1143-1146.

    [5]

    MIRA E. Improving the quality of life in patients with vestibular disorders:the role of medical treatments and physical rehabilitation[J]. Int J Clin Pract,2008,62:109-114.

    [6]

    HELMINSKI J O,ZEE D S,JANSSEN I,et al.Effective-ness of particle repositioning maneuvers in the treatment of benign paroxysmal positional vertigo:a systematic re-view[J].Phys Ther,2010,90:663-678.

    [7]

    OH S Y,KIM J S,JEONG S H,et al.Treatment of apo-geotropic benign positional vertigo:comparison of thera-peutic head-shaking and modied Semontfi maneuver[J].J Neurol,2009,256:1330-1336.

    [8]

    HAN G C,LEE E J,LEE J H,et al.The study of stand-ardization for a Korean adaptation of self-report measures of dizziness[J].J Korean Bal Soc,2004,3:307-325.

    [9]

    FARALLI M,MANZARI L,PANICHI R,et al.Subjec-tive visual vertical before and after treatment of a BPPV episode[J].Auris Nasus Larynx,2011,38:307-311.

    [10]

    KIM J S,MOON S Y,KIM K Y,et al.Ocular contra pul-sion in rostral medial medullary infarction[J].Neurolo-gy,2004,63:1325-1327.

    [11]

    FIFE T D.Benign paroxysmal positional vertigo[J].Se-min Neurol,2009,29:500-508.

    [12]

    SEOK J I,LEE H M,YOO J H,et al. Residual dizziness after successful repositioning treatment in patients with benign paroxysmal positional vertigo[J]. J Clin Neurol,2008,4:107-110.

    [13]

    LEE N H,KWON H J,BAN J H. Analysis of residual symptoms after treatment in benign paroxysmal positional vertigo using questionnaire[J]. Otolaryngol Head Neck Surg, 2009,141:232-236.

    [14]

    MENDEL B,BERGENIUS J,LANGIUS A. Dizziness symptom severity and impact on daily living as perceived by patients suffering from peripheral vestibular disorder[J]. Clin Otolaryngol Allied Sci,1999,24:286-293.

    [15]

    BRANDT T,DAROFF R B.Physical therapy for benign paroxysma positional vertigo[J]. Arch Otolaryngol,1980,106:484-485.

    [16]

    TJERNSTROM F,FRANSSON P A,HOLMBERG J,et al.Decreased postural adaptation in patients with phobic postural vertigo-an effect of an "anxious" control of pos-ture[J]?Neurosci Lett,2009,454:198-202.

    [17]

    BHATTACHARYYA N,BAUGH R F,ORVIDAS L,et al.Clinical practice guideline:benign paroxysmal posi-tional vertigo[J].Otolaryngol Head Neck Surg,2008,139:S47-81.

    [18]

    NIWA T,SHIRAGA T,ISHII I,et al.Contribution of hu-man hepatic cytochrome p450isoforms to the metabolism of psychotropic drugs[J].Biol Pharm Bull,2005,28:1711-1716.

    [19]

    JACOBSON G P,NEWMAN C W. The development of the Dizziness Handicap Inventory[J]. Arch Otolaryngol Head Neck Surg,1990,116:424-427.

    [20]

    SANNA E,BUSONERO F,TALANI G,et al.Low toler-ance and dependence liabilities of Etizolam:molecular,functional,and pharmacological correlates[J].Eur J Pharmacol,2005,519:31-42.

  • 加载中
计量
  • 文章访问数:  187
  • PDF下载数:  151
  • 施引文献:  0
出版历程

目录